Prime Therapeutics Companies earn URAC re-accreditation in Pharmacy Benefit Management
Designation demonstrates highest level of commitment to quality health careApril 13, 2023
EAGAN, Minn. – April 13, 2023 – Prime Therapeutics LLC (Prime) is proud to announce that its companies, Magellan Rx Management, LLC and Magellan Pharmacy Solutions, Inc., (Magellan Rx) have earned URAC re-accreditation for Pharmacy Benefit Management. URAC is the independent leader in promoting health care quality by setting high standards for clinical practice, consumer protections, performance measurement, operations infrastructure and risk management. By achieving this status, Magellan Rx demonstrates commitment to quality care, enhanced processes, patient safety and improved outcomes.
On Dec. 3, 2022, Prime finalized the acquisition of Magellan Rx, the pharmacy division of Magellan Health, from Centene Corporation. The agreement unites Prime’s strong foundation of pharmacy benefit management (PBM) capabilities with Magellan Rx’s industry-leading total specialty drug management expertise to create a diversified pharmacy solutions organization serving commercial markets and government programs.
“Retaining our URAC PBM accreditation is a testament to our commitment to continuous quality improvement for clinical care and program operations,” said Tamé Jaco, vice president of quality for Magellan Rx. “Congratulations to our clinical and program staff for continuing to highlight our dedication to ensuring patient safety and improving outcomes.”
URAC relies on a multidisciplinary advisory group to guide standards development, establish benchmarks and inform revisions. This group includes payers, physicians, hospitals, its Board of Directors, URAC’s Standards Committees and other industry experts. The standards are then circulated for public comment and beta-tested before their release. This broad, inclusive process assures that URAC’s standards promote industry best practices.
URAC’s comprehensive standards and associated elements of performance are organized into four foundational focus areas across all accreditation and certification programs:
- Risk management
- Operations infrastructure
- Performance monitoring and improvement
- Consumer protection and empowerment
Streamlining more than 40 core standards into these focus areas makes the process more seamless and enables URAC to conduct accreditation evaluations more quickly and efficiently.
“We applaud Magellan Rx on its subsidiaries Magellan Rx Management, LLC and Magellan Pharmacy Solutions, Inc. achieving URAC accreditation. With this distinction, Magellan Rx demonstrates excellence in quality health care delivery and their commitment to ensuring patient safety,” said URAC President and CEO Shawn Griffin, M.D.
May 25, 2023
Prime Therapeutics earns accreditation from the National Committee for Quality Assurance
EAGAN, Minn. – Prime Therapeutics LLC, a pharmacy benefit manager (PBM) serving nearly…
March 27, 2023
Prime Therapeutics announces Mostafa Kamal as president
Mostafa Kamal EAGAN, Minn. – Prime Therapeutics LLC (Prime), a pharmacy benefit manager (PBM)…
March 16, 2023
Prime Therapeutics and Magellan Rx to present seven managed care pharmacy research studies at AMCP conference
EAGAN, Minn. – March 16, 2023 – Leading pharmacy benefit manager (PBM) Prime…